GLIACURE, INC.

Profile

Company Names

GLIACURE, INC.

Addresses

234 CAUSEWAY STREET, #809, BOSTON, MA 02114

1005 RIVER BIRCH ROAD, MIDDLETON, WI 53562

Phone Numbers

617-532-0358
610-246-6012

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$8,378,022.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-08-17 
$1,577,996.00 
$1,577,996.00 
$0.00 
Equity 
2
2014-04-30 
$5,800,026.00 
$6,000,001.00 
$199,975.00 
Equity 
1
2012-02-17 
$1,000,000.00 
$2,750,000.00 
$1,750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WALTER 
 
DEWEY 
DIRECTOR, EXECUTIVE OFFICER
NERITES CORP   |  NEI III LLC   |  GLIACURE, INC.   |  INVESTABLE EMERGING MARKETS COUNTRY FUND   |  EMERGING (FREE) MARKETS COUNTRY FUND   |  EMERGING MARKETS COUNTRY FUND   |  DOOR COUNTY BREWING CO., LLC   |  IMBED BIOSCIENCES, INC
PHILIP 
 
HAYDON 
EXECUTIVE OFFICER, DIRECTOR
GLIACURE, INC.
YOLANDE 
 
HAYDON 
EXECUTIVE OFFICER
GLIACURE, INC.
MICHAEL 
 
SZULCZEWSKI 
EXECUTIVE OFFICER, DIRECTOR
GLIACURE, INC.
JOSEPH 
S. 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ACCELERON PHARMA INC   |  INVESTABLE EMERGING MARKETS COUNTRY FUND   |  EMERGING (FREE) MARKETS COUNTRY FUND   |  GLIACURE, INC.   |  EMERGING MARKETS COUNTRY FUND   |  CERECIN INC.   |  CYTEIR THERAPEUTICS, INC.   |  AN2 THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-09-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-17 
2014-08-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-30 
2014-05-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-30 
2012-02-29
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2012-02-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#